Journal of Affective Disorders
Volume 105, Issue 1 , Pages 81-91 , January 2008

The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning

  • Oliver H. Günther

      Affiliations

    • Health Economics Research Unit, University of Leipzig, Johannisallee 20, 04317 Leipzig, Germany
    • Department of Psychiatry, University of Leipzig, Johannisallee 20, 04317 Leipzig, Germany
    • Corresponding Author InformationCorresponding author. University of Leipzig, Health Economics Research Unit, Department of Psychiatry, Johannisallee 20, D-04317 Leipzig, Germany. Tel.: +49 341 97 24560; fax: +49 341 97 24569.
    • ,
  • Christiane Roick

      Affiliations

    • Department of Psychiatry, University of Leipzig, Johannisallee 20, 04317 Leipzig, Germany
    • ,
  • Matthias C. Angermeyer

      Affiliations

    • Department of Psychiatry, University of Leipzig, Johannisallee 20, 04317 Leipzig, Germany
    • ,
  • Hans-Helmut König

      Affiliations

    • Health Economics Research Unit, University of Leipzig, Johannisallee 20, 04317 Leipzig, Germany
    • Department of Psychiatry, University of Leipzig, Johannisallee 20, 04317 Leipzig, Germany

Received 25 January 2007 ,Revised 20 April 2007 ,Accepted 20 April 2007.

References 

  1. Angermeyer MC, Kilian R, Matschinger H. Handbuch für die deutsche Version der WHO Instrumente zur Erfassung der Lebensqualität, Hogrefe Verlag. 2000;
  2. Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. J. Clin. Epidemiol. 2001;54:1204–1217
  3. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ. The Bech–Rafaelsen mania scale and the hamilton depression scale. Acta Psychiatr. Scand. 1979;59:420–430
  4. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13:873–884
  5. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72
  6. Cohen J. Statistical Power Analysis for Behavioral Science. 2 edn.. Hilsdale, NJ: Lawrence Earlbaum Associates; 1988;
  7. Dolan P. Modeling valuations for EuroQol health states. Med. Care. 1997;35:1095–1108
  8. Dolan P. Whose preferences count?. Med. Decis. Mak. 1999;19:482–486
  9. Drummond M, Jonsson B, Rutten F. The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy. 1997;40:199–215
  10. Food and Drug Administration . Draft guidance for industry patient reported outcome measures: use in medical product development in support labeling claims. Fed. Regist. 2006;71:5862–5863
  11. Gold M, Siegel J, Russel L, Weinstein M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996;
  12. Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatry. 1992;149:1148–1156
  13. Greiner W, Claes C, Busschbach JJ, Graf von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur. J. Health Econ. 2004;6:124–130
  14. Guy W. CGI, ECDEU assessment manual for psychopharmacology. In: US Departement of Health, Education, and Welfare. 1976;p. 76–338
  15. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J. Chronic. Dis. 1987;40:171–178
  16. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin. Proc. 2002;77:371–383Notes: CORPORATE NAME: Clinical Significance Consensus Meeting Group
  17. Hayhurst H, Palmer S, Abbott R, Johnson T, Scott J. Measuring health related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures. Qual. Life Res. 2006;15:1271–1280
  18. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control. Clin. Trials. 1989;10:407–415
  19. König HH, Roick C, Angermeyer MC. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. Eur. Psychiatr. 2006;22:177–187
  20. Krabbe PF, Peerenboom L, Langenhoff BS, Ruers TJ. Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30. Qual. Life Res. 2004;13:1247–1253
  21. Lamers LM, Bouwmans CA, van Straten A, Donker MC, Hakkaart L. Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ. 2006;15:1229–1236
  22. Licht RW, Qvitzau S, Allerup P, Bech P. Validation of the Bech–Rafaelsen melancholia scale and the hamilton depression scale in patients with major depression; is the total score a valid measure of illness severity?. Acta Psychiatr. Scand. 2005;111:144–149
  23. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J. Clin. Epidemiol. 1997;50:869–879
  24. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med. Care. 2003;41:582–592
  25. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen. Hosp. Psych. 2004;26:13–17
  26. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual. Life Res. 2000;9:887–900
  27. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual. Life Outcomes. 2006;4:70
  28. Roick C, Deister A, Zeichner D, Birker T, Konig HH, Angermeyer MC. The regional budget for mental health care: a new approach to combine inpatient and outpatient care. Psychiatr. Prax. 2005;32:177–184
  29. Sapin C, Fantino B, Nowicki ML, Kind P. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual. Life Outcomes. 2004;2:20
  30. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care. 2005;43:203–220
  31. Skevington SM, Wright A. Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100. Br. J. Psychiatry. 2001;178:261–267
  32. Sprangers MA, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA. Assessing meaningful change in quality of life over time: a users' guide for clinicians. Mayo Clin. Proc. 2002;77:561–571
  33. Supina AL, Johnson JA, Patten SB, Williams JV, Maxwell CJ. The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety. Qual. Life Res. 2007;16:749–754
  34. The EuroQol Group . EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol group. Health Policy. 1990;16:199–208
  35. WHOQOLGroup . Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med. 1998;28:551–558
  36. Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J. Clin. Epidemiol. 2003;56:52–60
  37. Willige van de G, Wiersma D, Nienhuis FJ, Jenner JA. Changes in quality of life in chronic psychiatric patients: a comparison between EuroQol (EQ-5D) and WHOQoL. Qual. Life Res. 2005;14:441–451
  38. World Health Organization . International Statistical Classification of Diseases and Related Health Problems — Tenth Revision. 2004;

☆ Conflict of interest: All authors declare that they have no conflicts of interest.Contributors: All authors contributed to and have approved the final manuscript:Oliver H. Günther undertook the statistical analyze and wrote the first draft and the final version of manuscript. Christiane Roick designed the study and managed the process of data collection. Matthias C. Angermeyer planned the study and reviewed the final manuscript. Hans-Helmut König analyzed the data and reviewed the first draft.Role of funding source: Funding for this study was provided by German Statutory Health Insurance (grant number 932000-050) and the German Federal Ministry of Education and Research (grant number 01ZZ0106); both had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.

PII: S0165-0327(07)00142-5

doi: 10.1016/j.jad.2007.04.018

Journal of Affective Disorders
Volume 105, Issue 1 , Pages 81-91 , January 2008

Article Tools

* Image Usage & Resolution